A. Bona

Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection

W. Rozenbaum, N. Clumeck, F. Castelli, 1996, AIDS.

Successful Direct-Acting Antiviral Therapy (DAA) in HIV/HCV Co-Infected Patients Fails to Restore Circulating Mucosal-Associated Invariant T Cells (MAITs)

P. Klenerman, G. Marchetti, A. Monforte, 2019 .

Naive HIV/HCV-Coinfected Patients Have Higher Intrahepatic Pro-Inflammatory Cytokines than Coinfected Patients Treated with Antiretroviral Therapy

A. Lazzarin, C. Paties, G. Sitia, 2005, Antiviral therapy.

Recombinant interferon‐alpha therapy and meno‐metrorrhagia

R. Finazzi, C. Uberti-Foppa, A. Bona, 1998, British journal of obstetrics and gynaecology.

Dyslipidaemia after switch to tenofovir alafenamide (TAF)‐based cART regimens in a cohort of HIV‐positive patients: what clinical relevance?

A. d’Arminio Monforte, D. Mondatore, G. Tagliaferri, 2020, HIV medicine.

Acute self-limiting hepatitis C after possible sexual exposure: sequence analysis of the E-2 region of the infected patient and sexual partner.

A. Lazzarin, G. Sitia, G. Tambussi, 2001, Scandinavian journal of infectious diseases.

Use of polymerase chain reaction assays of aqueous humor in the differential diagnosis of retinitis in patients infected with human immunodeficiency virus.

A. Lazzarin, P. Cinque, A. Castagna, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.